Spotlight On... Pathway Genomics pays $4M to settle kickback claims; Pande discusses Andreessen Horowitz's $200M bio fund; NIH sets mHealth evidence goal; and more...

Pathway Genomics has agreed to pay $4 million to settle a dispute with the U.S. Department of Justice (DOJ). The genomic testing lab was accused of providing kickbacks to healthcare providers in return for patient referrals. In a statement to reveal the settlement, Pathway said it isn't admitting to any wrongdoing and "may debate some of the merits of the DOJ's allegations." Release | More

> Vijay Pande outlined his vision for Andreessen Horowitz's $200 million bio fund. Q&A

> The NIH committed to generating evidence on mHealth apps by 2020. Article

> Datatrak continued to fightback against activist investors ahead of its upcoming annual meeting. Release

> OmniComm Systems revealed a biopharma company is using its EDC system across its entire pipeline. More

> EnsoData discussed its use of software to speed up the analysis of sleep data. Piece